Daniel Karlin

Company: MindMed

Job title: Chief Medical Officer

Seminars:

Workshop C: Navigating Evolving Regulatory Hurdles in an Era of Growing Potential for Psychedelic Drug Approvals 1:00 pm

As psychedelic drug assets progress into late phase clinical studies, there are some critical questions at the forefront of everybody’s minds: What is the optimal amount of psychological support that is necessary from a regulatory perspective in clinical trials for psychedelics? What are regulatory agencies looking for in terms of higher quality evidence or more…Read more

day: Pre-Conf Day - C